A cyclin-dependent kinase inhibitor, Dacapo, is necessary for timely exit from the cell cycle during Drosophila embryogenesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8980230.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
In a screen for genes that interact with the Rap1 GTPase, we have identified a Drosophila gene, dacapo (dap), which is a member of the p21/p27 family of cdk inhibitors. Unlike mammalian cdk inhibitors studied to date, dap is essential for normal embryonic development. Dacapo inhibits cyclin-cdk activity in vitro. Overexpressing dap during eye development interferes with cell cycle progression and interacts genetically with the retinoblastoma homolog (Rbf) and cyclin E. dap expression in embryos parallels the exit of cells from the cell cycle. dap mutant embryos delay the normal cell cycle exit during development; many cells complete an additional cycle and subsequently become quiescent. Thus, dap functions during embryogenesis to achieve a precisely timed exit from the cell cycle.
Medical subject headings
- CDC2-CDC28 Kinases
- Cell Cycle
- Cyclin-Dependent Kinases
- Cyclins
- Drosophila Proteins
- Drosophila melanogaster
- Growth Inhibitors
- Insect Proteins
- Nuclear Proteins
- Protein Kinases
- Protein Serine-Threonine Kinases